SKI Market

A+| A| A-|

Indian Indices

Sensex

77,328.19 -516.33
( -0.66%)

Global Indices

Nasdaq

49,619.91 1.93
(0.00%)

Dow Jones

7,417.79 59.68
(0.81%)

Hang Seng

62,681.30 -152.54
(-0.24%)

Nikkei 225

10,228.01 -48.94
(-0.48%)

Forex

USD-INR

94.38 -0.30
(-0.31%)

EUR-INR

110.93 -0.26
(-0.23%)

GBP-INR

128.32 -0.39
(-0.30%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

267.3488556

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

30.42

15438.07

EPS(TTM)

Face Value()

Div & Yield %

25.82

1.4

Back

Ishita Drugs & Industries standalone net profit declines 26.32% in the September 2025 quarter

Nov 12,2025

Net profit of Ishita Drugs & Industries declined 26.32% to Rs 0.14 crore in the quarter ended September 2025 as against Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 6.12% to Rs 3.07 crore in the quarter ended September 2025 as against Rs 3.27 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3.07	3.27	-6
OPM %	5.86	7.03	-
PBDT	0.25	0.28	-11
PBT	0.22	0.25	-12
NP	0.14	0.19	-26

77,328.19 -516.33 ( -0.66%)

49,619.91 1.93 (0.00%)

7,417.79 59.68 (0.81%)

62,681.30 -152.54 (-0.24%)

10,228.01 -48.94 (-0.48%)

94.38 -0.30 (-0.31%)

110.93 -0.26 (-0.23%)

128.32 -0.39 (-0.30%)

0.60 0.00 (-0.28%)